CIAM
ALXO icon

Caitong International Asset Management’s ALX Oncology ALXO Stock Holding History

Caitong International Asset Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12 Buy
+6
New +$11 ﹤0.01% 2120
2025
Q2 		– Sell
-119
Closed -$74 – 1971
2025
Q1 		$74 Buy
119
+39
+49% +$47 ﹤0.01% 2005
2024
Q4 		$134 Buy
+80
New +$123 ﹤0.01% 1603

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Caitong International Asset Management's ALXO Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in ALX Oncology (ALXO) in Q1 2026: 6 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #2120 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in ALXO as recently as Q1 2025.

Caitong International Asset Management first reported a position in ALXO in Q4 2024 and has held it in 3 quarters since. The position peaked at $134 in Q4 2024. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Caitong International Asset Management held 6 shares of ALX Oncology worth $12 as of Q1 2026.
  • ALX Oncology was a new Caitong International Asset Management position in Q1 2026.
  • ALX Oncology made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2120 holding.
  • Caitong International Asset Management first reported a position in ALX Oncology in Q4 2024 and has held it in 3 quarters since.
  • Caitong International Asset Management's ALX Oncology position peaked at $134 in Q4 2024.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.